Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
84.315,60
-0,04%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Shuttle Pharmaceuticals Holdings Inc (SHPH) Shuttle Pharmaceuticals Holdings Inc (SHPH) Notizie

SHPH

Shuttle Pharmaceuticals (SHPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SHPH
DataOraFonteTitoloSimboloCompagnia
13/03/202521:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
13/03/202521:10GlobeNewswire Inc.Shuttle Pharma Announces Closing of $5.75 Million Underwritten OfferingNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
13/03/202511:36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
12/03/202514:24GlobeNewswire Inc.Shuttle Pharma Announces Pricing of $5.75 Million Underwritten OfferingNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
12/03/202511:20GlobeNewswire Inc.Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business ActivitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
10/03/202505:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
05/03/202512:48Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
26/02/202516:45GlobeNewswire Inc.Shuttle Pharma Provides Corporate Update and Reports 2024 ResultsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
26/02/202516:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
07/02/202501:34Edgar (US Regulatory)Form 5/A - Annual statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
05/02/202522:55Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
21/01/202515:00GlobeNewswire Inc.Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
13/01/202514:56AllPennyStocks.comInvestors Watching Two Small-Caps for News on Potential Major Advancements in Cancer TreatmentsNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
07/01/202515:00GlobeNewswire Inc.Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
19/12/202415:00GlobeNewswire Inc.Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development ProgramNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
26/11/202415:00GlobeNewswire Inc.Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First PatientNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
13/11/202423:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
13/11/202423:00GlobeNewswire Inc.Shuttle Pharma Provides Third Quarter 2024 Corporate UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
30/10/202402:05GlobeNewswire Inc.Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
29/10/202421:05GlobeNewswire Inc.Shuttle Pharma Pays Off Senior Secured Convertible NoteNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
29/10/202417:55AllPennyStocks.comMicro Cap Company Is Soaring On Phase 2 Trial UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
29/10/202414:00GlobeNewswire Inc.Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
28/10/202421:05GlobeNewswire Inc.Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
28/10/202414:00GlobeNewswire Inc.Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
25/10/202414:49Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
09/10/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
16/09/202415:00GlobeNewswire Inc.Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
05/09/202415:00GlobeNewswire Inc.Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human DiseaseNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
04/09/202422:15GlobeNewswire Inc.Shuttle Pharma Provides Second Quarter 2024 Corporate UpdateNASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
04/09/202403:52Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:SHPHShuttle Pharmaceuticals Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SHPH

La tua Cronologia

NASDAQ
JAKRX
John Hancock Disciplined...
KUCN
OMGUSDT
OMG Network
LBNK
DAGSUSDT
Dagcoin
NASDAQ
CDWTX
Ci Global Income & Growt...
EU
NLTEL
AEX Telecommunications
NASDAQ
RACYU
Relativity Acquisition
OKEX
ICXUSDT
ICON
NASDAQ
CAHAX
Canoe Defensive Global E...
GATE
FIOUSDT
FIO Token
NASDAQ
ABNYJXX
Bank of Montreal Capped ...
GEMN
LUNAUSD
Terra Luna Classic
BOV
CEBR5R
CEB PNA
BOV
WTCM5L
WTC PNA
LATK
BZTETH
Bloomzed Token
EU
BFCDF
Banque Federative du Cre...
NASDAQ
CDROX
Ci Global Equity Corpora...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci